- Home
- FTRE vs PDO Comparison
FTRE vs PDO Comparison
Compare FTRE & PDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTRE
- PDO
- Stock Information
- Founded
- FTRE 1996
- PDO 2020
- Country
- FTRE United States
- PDO United States
- Employees
- FTRE N/A
- PDO N/A
- Industry
- FTRE Medical Specialities
- PDO Trusts Except Educational Religious and Charitable
- Sector
- FTRE Health Care
- PDO Finance
- Exchange
- FTRE Nasdaq
- PDO Nasdaq
- Market Cap
- FTRE 1.4B
- PDO 1.7B
- IPO Year
- FTRE N/A
- PDO N/A
- Fundamental
- Price
- FTRE $9.58
- PDO $13.57
- Analyst Decision
- FTRE Hold
- PDO
- Analyst Count
- FTRE 11
- PDO 0
- Target Price
- FTRE $20.30
- PDO N/A
- AVG Volume (30 Days)
- FTRE 2.2M
- PDO 520.0K
- Earning Date
- FTRE 03-03-2025
- PDO 01-01-0001
- Dividend Yield
- FTRE N/A
- PDO 11.80%
- EPS Growth
- FTRE N/A
- PDO N/A
- EPS
- FTRE N/A
- PDO N/A
- Revenue
- FTRE $2,696,400,000.00
- PDO N/A
- Revenue This Year
- FTRE N/A
- PDO N/A
- Revenue Next Year
- FTRE $5.67
- PDO N/A
- P/E Ratio
- FTRE N/A
- PDO N/A
- Revenue Growth
- FTRE N/A
- PDO N/A
- 52 Week Low
- FTRE $9.47
- PDO $10.65
- 52 Week High
- FTRE $41.02
- PDO $13.31
- Technical
- Relative Strength Index (RSI)
- FTRE 19.64
- PDO 32.59
- Support Level
- FTRE $9.76
- PDO $13.77
- Resistance Level
- FTRE $11.12
- PDO $14.12
- Average True Range (ATR)
- FTRE 0.95
- PDO 0.13
- MACD
- FTRE -0.24
- PDO -0.05
- Stochastic Oscillator
- FTRE 1.75
- PDO 0.89
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.
About PDO PIMCO Dynamic Income Opportunities Fund of Beneficial Interest
PIMCO Dynamic Income Opportunities Fund is a closed-end management investment company. The fund's primary investment objective is to generate a level of income that is higher than that generated by high-quality, intermediate-term U.S. debt securities.